The union for managers and professionals in public service
Home  >  News and media  >  News  >  FDA calls for “comprehensive” pay reform at NCA “to build a workforce for the future”
Tuesday 01 March 2022

FDA calls for “comprehensive” pay reform at NCA “to build a workforce for the future”

Willy Barton/Shutterstock.com

The FDA has published its evidence to the National Crime Agency's Pay Review Body, calling for comprehensive pay reform at the NCA, to ensure the Agency has a sustainable strategy attract and retain staff to meet future challenges.

The FDA, which represents senior managers and leaders in the NCA, has called for a pay and reward strategy that is “fit for purpose” and can address existing gaps in skills and expertise.

FDA National Officer for the NCA, Wynne Parry said:

“The NCA has achieved much in disrupting organised crime. In recognising this, the Home Secretary has acknowledged that the past year has seen an increase in challenges faced by the Agency, not least as a result of constantly evolving technologies as well as the COVID-19 pandemic.

“These challenges can only be met through the ability to attract and retain staff with the requisite capabilities. Building a workforce for the future – including many who may not yet be working in the police or in government - requires the Agency’s reward strategy to be sustainable. It also needs to be fit for purpose. Evidence is mounting that many of the most significant risks to the NCA’s plans and commitments, including efforts to control costs, are the result of gaps in skills and expertise.

“We have restated our vision for a more comprehensive version of reform, one that embraces all employees so that they gain tangible benefits.”

You can read the FDA's full evidence submission here.

16th May 2024
Catch up on the keynote speeches from Dave Penman and Mark Drakeford from this year's Annual Delegate Conference
10th May 2024
At this year's FDA Annual Delegate Conference attendees heard from keynote speakers Dave Penman, Cat Little, Mark Drakeford and Paul Whiteman.
Find us
FDA, Centenary House, 93-95 Borough High Street, London, SE1 1NL                      
Copyright © 2024 FDA